Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.
Shin EJ, Jeong JH, Hwang Y, Sharma N, Dang DK, Nguyen BT, Nah SY, Jang CG, Bing G, Nabeshima T, Kim HC.
Shin EJ, et al. Among authors: bing g.
Arch Pharm Res. 2021 Jul;44(7):668-688. doi: 10.1007/s12272-021-01341-7. Epub 2021 Jul 20.
Arch Pharm Res. 2021.
PMID: 34286473
Review.